4//SEC Filing
Erlander Mark 4
Accession 0001104659-20-000881
CIK 0001213037other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:15 PM ET
Size
9.5 KB
Accession
0001104659-20-000881
Insider Transaction Report
Form 4
Trovagene, Inc.TROV
Erlander Mark
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2020-01-02+261→ 6,492 total - Tax Payment
Common Stock
2020-01-03−116→ 6,376 total - Exercise/Conversion
Restricted Stock Units
2020-01-02−261→ 260 total→ Common Stock (261 underlying)
Footnotes (4)
- [F1]Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On January 4, 2017, the reporting person was granted 1,459 restricted stock units, 261 of which vested on January 2, 2020. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on January 4, 2017.
- [F2]The reporting person is reporting the withholding by Trovagene, Inc. of 116 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on January 2, 2020.
- [F3]Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock.
- [F4]On January 4, 2017, the reporting person was granted 1,459 restricted stock units, 261 of which vested on January 2, 2020. The common stock into which such vested restricted stock units converted on January 2, 2020 is reported in Table I on this Form 4.
Documents
Issuer
Trovagene, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001651537
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:15 PM ET
- Size
- 9.5 KB